Research identifies motile vesicles that encapsulate genomic DNA in cancer cells, suggesting new roles in migration and metastasis.
Abstract Migrating cancer cells emit a diverse array of extracellular vesicles (EVs) that carry bioactive molecules, including DNA, which may mediate intercellular communication and metastatic progression. However, the mechanisms and biological significance of DNA packaging in EVs remain poorly understood. Here, we identify and characterize a novel class of large EVs (2–5 μm), termed Motile Vesicles (MoVes), which are selectively released during cancer cell migration and closely associated with epithelial–mesenchymal transition (EMT). Using scanning electron microscopy and live-cell imaging, we show that MoVes are actively shed by cancer cells—a phenomenon absent in normal epithelial cells. Whole-genome sequencing reveals that MoVes encapsulate the full genomic content of their parent cells, faithfully reflecting their mutational landscape. Proteomic profiling further distinguishes MoVes from other EV subtypes, with FAM3C—an interleukin-like EMT inducer—emerging as a specific molecular marker. These findings define MoVes as a cancer-specific EV population that carries genomic DNA during EMT and migration, unveiling new insights into extracellular DNA biology and potential mechanisms of cancer progression and metastatic dissemination.
No takes yet. Share an insight, caveat, or question.
Burnier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: